Temperature Regulation in Depression: Functional 5HT1A Receptor Adaptation Differentiates Antidepressant Response

Abstract

Observations in humans and animals have indicated that chronic, but not acute, antidepressant treatment (ADT) can desensitize 5-HT1A receptor-mediated responses, such as hypothermia. We hypothesized that 5-HT1A desensitization would be necessary for an antidepressant response (ADR) to occur. To test this hypothesis, we examined 5HT1A-agonist ipsapirone (IPS)-induced hypothermia in 28 depressed patients being treated with fixed doses of nortriptyline (75 mg) at 3-day and 3-week treatment points. Decreases in 24-item Hamilton scores (412) were used to dichotomize the response data into ADR groups of 13 responders (ADR + ) and 15 nonresponders (ADRÀ). A two-way repeated measures analysis of variance indicated significant temperature differences in the area under the curve between response groups across time from 3-day to 3-week intervals (df ¼ 1, 26, F ¼ 6.6, po0.02). In comparison to 3 days treatment, at 3 weeks, the ADR + patients showed blunted hypothermic responses to IPS. ADRÀ did not show this effect, implicating ADR + patients to be less responsive to 5HT1A-receptor stimulation after 3 weeks treatment. Similar effects were not found for 5HT1A postsynaptically mediated ACTH and cortisol responses. These results indicate that to achieve ADR, serotonergic neurotransmission needs to be altered as reflected by the change in 5-HT1a receptor responsiveness documented herein.

Comparing outcomes of adjunctive treatment in depression: Aripiprazole versus Bupropion

“…While the exact neurobiological mechanism of depression is unknown, data suggests that disruption of the dopamine and norepinephrine systems may play a role in the progression of the disease (Haenisch and Bonisch, 2011;Trivedi et al, 2008). Moreover, data suggest that modulation of the 5HT1A receptor may play a crucial role in antidepressant actions (Noro et al, 2010;Rausch et al, 2006;Theodore et al, 2007). By using adjunctive therapy, more neurotransmitter systems can be targeted, increasing the clinical efficacy, ultimately providing relief to depression patients.…”

Genetic association between helpless trait and depression-related phenotypes: evidence from crossbreeding studies with H/Rouen and NH/Rouen mice

“…The selective serotonin reuptake inhibitors (SSRIs), in particular, have allowed important progress towards understanding the role of 5-HT in depression. Moreover, recent data point to alterations of different 5-HT receptors in the brain of depressed patients, especially 5-HT 1A receptors (Lemonde et al 2004 ;Parsey et al 2006 ;Rausch et al 2006), 5-HT 1B receptors (Svenningsson et al 2006) and 5-HT 2C receptors (Gurevich et al 2002).…”

Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression

“…Although the precise mechanisms for the role of 5-HT 1A activity in MDD are not fully elucidated, both the overall antidepressant effect, the speed of onset and other pharmacological effects may be attributed to desensitization of this autoreceptor and removal of negative feedback on serotonin production and release [33].…”